Evolus (EOLS) Cash from Operations (2017 - 2026)
Evolus (EOLS) posted Cash from Operations of 9952000.0 for Q1 2026, down 177.59% on a QoQ basis from 12827000.0 in Q4 2025, and up 36.34% year-over-year from 7299627.63 in Q1 2025.
Evolus (EOLS) Cash from Operations (2017 - 2026) Analysis & Trends
Evolus' Cash from Operations history runs 10 years deep, the most recent figure standing at 9952000.0 for Q1 2026.
- Quarterly Cash from Operations rose 36.34% year-over-year to 9952000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36585000.0 (down 58.95% YoY) and the FY2025 annual result came in at 42265000.0, down 134.82% from the prior year.
- Cash from Operations was 9952000.0 for Q1 2026 at Evolus, down from 12827000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 12827000.0 in Q4 2025 and bottomed at 38199000.0 in Q1 2022.
- A 5-year average of 11125647.06 and a median of 10615000.0 in 2024 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 491.39% in 2024, while the deepest fall reached 519.26% in 2024.
- Evolus' Cash from Operations stood at 8774000.0 in 2022, then jumped by 109.27% to 813000.0 in 2023, then jumped by 491.39% to 4808000.0 in 2024, then jumped by 166.78% to 12827000.0 in 2025, then slumped by 177.59% to 9952000.0 in 2026.
- Business Quant data shows EOLS's Cash from Operations at 9952000.0 in Q1 2026, 12827000.0 in Q4 2025, and 14669000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Evolus | 390.47 Mn | 340.68 Mn | 48.90 Mn | -9.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.95 Mn |
| Mar 31, 2026 | -9.95 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Sep 30, 2025 | -14.67 Mn |
| Sep 30, 2025 | -14.67 Mn |
| Jun 30, 2025 | -24.79 Mn |
| Jun 30, 2025 | -24.79 Mn |
| Mar 31, 2025 | -15.63 Mn |
| Mar 31, 2025 | -15.63 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Jun 30, 2024 | -6.47 Mn |
| Jun 30, 2024 | -6.47 Mn |
| Mar 31, 2024 | -10.62 Mn |
| Mar 31, 2024 | -10.62 Mn |
| Dec 31, 2023 | 813,000.00 |
| Dec 31, 2023 | 813,000.00 |